Vaccine
-
Over 190.65 crore Covid vaccine doses administered in India: Govt
India | May 11, 2022, 03:00 AM ISTA total of 38,476 precaution doses of the vaccines were administered to beneficiaries aged 18-59 years till 7 pm, taking the total number of such doses given in this age-group to 11,78,161, according to the ministry's data.
-
Oral Covid vaccine protects against disease, transmission: Study
World | May 09, 2022, 04:11 PM ISTThe research, published in the journal Science Translational Medicine, demonstrates the potential of the vaccine to work through the mucosal tissue to neutralize SARS-CoV-2, limiting infections and the spread of the active virus in airborne particles.
-
COVID: India's vaccination coverage exceeds 189.17 crore, says health ministry
India | May 01, 2022, 02:30 PM ISTSimilarly, COVID precaution dose administration for the age group 18-59 yrs also started from April 10, 2022, onwards, it stated.
-
SEC seeks more data from Serum Institute over COVID vaccine 'Covovax' for 7-12 age group: Sources
India | Apr 30, 2022, 07:40 AM ISTCovovax has already been recommended by the Drugs Controller General of India for children above 12 years of age, but its administration has not been allowed yet.
-
China's zero Covid tolerance strategy fails! Vaccine efficacy under scanner as record cases surface
World | Apr 13, 2022, 04:55 PM ISTChina has always been notorious about revealing the actual data of new Covid cases, deaths to the world. Most of the people in China have been given the 'Made in China' vaccine like Sinopharm but this hasn't been that effective compared to other vaccines.
-
India approves COVID-19 precautionary dose for all adults. Why and when to get the extra shot?
Health | Apr 09, 2022, 05:52 PM ISTIn India, precautionary dose of COVID-19 vaccines will be available to all aged above 18 years at private vaccination centers from April 10. Data suggest that a booster dose provides good short-term vaccine effectiveness and has a safety profile similar to the second dose of the vaccine.
-
India may come up with vaccine against tuberculosis by 2024, says Indian scientist
India | Apr 01, 2022, 11:32 PM ISTDr. Suchit Kamble, a scientist at the ICMR-National AIDS Research Institute (NARI) in Pune, informed us that the trials are underway to evaluate the efficacy and safety of two TB vaccine candidates -- VPM1002 and Immunovac -- in preventing tuberculosis in healthy household contacts of newly-diagnosed sputum positive pulmonary TB patients.
-
100 per cent of Delhi's eligible population received 1st COVID vaccine dose, 90 pc second: Sisodia
India | Mar 25, 2022, 02:28 PM ISTManish Sisodia, who also holds Finance portfolio, was presenting the status report of the Delhi gov's Outcome Budget for the year 2021-21 in the House.
-
COVID: France to start administering 4th vaccine dose
World | Mar 13, 2022, 01:02 PM ISTThe vaccination campaign will also be extended to people having an immunocompromised system who were not eligible for the vaccine until now, Le Parisien reported.
-
COVID: India's vaccination coverage crosses 180 crore landmark
India | Mar 13, 2022, 08:32 AM ISTHealth Minister Dr Mansukh Mandaviya congratulated the nation on achieving this historic landmark milestone of 180 crore landmark.
-
'Might order probe': Supreme Court on fake medical certificates for COVID death ex-gratia
India | Mar 07, 2022, 02:07 PM ISTSolicitor General Tushar Mehta, representing the Centre, submitted before a bench headed by Justice MR Shah that an outer-limit may be fixed for submitting Covid death-related claims, otherwise the process will become endless.
-
COVID: Over 2 crore precaution doses administered among eligible beneficiaries, says Mandaviya
India | Mar 04, 2022, 02:19 PM ISTAdditionally, over 97 pc of India's adult population have also received their first dose of vaccine against COVID.
-
COVID pandemic: India's vaccination coverage exceeds 177.17 crore
India | Feb 26, 2022, 01:50 PM ISTThis has been achieved through 2,02,74,848 sessions, said the ministry. According to them, 23,598 patients have recovered in last 24 hours and cumulative tally of recovered patients is now at 4,22,70,482.
-
COVID pandemic: India's vaccination coverage crosses 172.29 crores
India | Feb 12, 2022, 02:33 PM IST"With the administration of over 46.82 lakh (46,82,662) vaccine doses in the last 24 hours, India's COVID-19 vaccination coverage has exceeded 172.29 Cr (1,72,29,47,688) as per provisional reports till 7 am today," the ministry said in a press release.
-
COVID: Centre requests States, UTs to accelerate 2nd dose coverage among 15-18 age group
India | Feb 02, 2022, 02:52 PM ISTWith proactive efforts of States/UTs, along with Govt of India, Centre has administered over 66.68 cr doses of COVID vaccine which is amongst the highest in the world.
-
COVID: Over 12.79 crore unutilized vaccine doses available with States, UTs
India | Jan 22, 2022, 11:44 AM ISTThe nationwide COVID vaccination started on January 16, 2021.The new phase of universalization of COVID vaccination commenced from June 21, 2021.
-
Google doodle stresses on importance of masks, vaccination amid Omicron threat
Trending | Jan 17, 2022, 01:00 PM ISTGoogle doodle stressed on the importance of wearing masks and getting vaccinated in the fight against the virus threat and emerging cases on Omicron variant. On Sunday, India completed one year of administering COVID-19 vaccines.
-
Covid vaccines for children around the world: All you should know
Health | Jan 06, 2022, 02:34 PM ISTChildren are at a huge risk of COVID-19 infection, especially with the mutations the virus is going through. As India braces for the third wave, here is a look at vaccine choices that are available for young kids around the world.
-
Karnataka to jab 31 lakh beneficiaries in 15-18 age group, 12 lakh elders from January 3
India | Dec 30, 2021, 01:44 PM ISTSources in the health dept stated that till date, the state govt has vaccinated 76 pc of the targeted population against COVID.
-
Omicron antibodies that can block variant identified
India | Dec 29, 2021, 05:09 PM ISTThe research, published in the journal Nature, may help design vaccines and antibody treatments that will be effective against not only Omicron but other variants that may emerge in the future.